Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Journal of Translational Medicine

Fig. 4

From: C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

Fig. 4

C14orf166 knockdown inhibited the proliferation of bladder cancer cell lines. a Western blot determination of the effect of C14orf166 siRNAs in bladder cancer RT4 and T24 cells. b Quantitative RT-PCR determination of the effect of C14orf166 siRNAs in bladder cancer RT4 and T24 cells. Transcription levels were normalized to GAPDH expression. c MTT assay determination of bladder cancer RT4 and T24 cell proliferation following C14orf166 downregulation. d Colony formation assay determination of the effect of C14orf166 downregulation on cell proliferation. *P < 0.05

Back to article page